Establishment Labs

Establishment Labs is a medical technology company with a strong emphasis on innovation that designs, develops, manufactures and markets an innovative product portfolio. Its CE-marked Motiva Implants® line of silicone breast implants (http://www.motivaimplants.com) utilizes ultra-high purity medical-grade silicone and is subject to the strictest quality assurance testing throughout the manufacturing process. Motiva Implants are sold in more than 60 countries worldwide. Puregraft®’s FDA cleared and CE-Marked technology provides plastic surgeons with purified fat for reinjection on the sterile field and is used in hospitals and clinics around the world. Divina® is a proprietary 3D imaging technology for full integration in consultation and surgical planning of unique solutions for breast aesthetics and reconstruction. All manufacturing facilities are fully compliant with both FDA and ISO applicable standards.

Establishment Labs headquartered in New York, New York, United States, North America, operates in the Biotechnology, Health Care, Manufacturing, Medical Device sector. The company focuses on Biotechnology and has secured $67.9B in funding across 128 round(s). With a team of 501-1000 employees, Establishment Labs is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Establishment Labs, raised $20.0M. Discover more about their projects, partnerships, and impact on our platform.